Success and failure in TB surveillance in Hungary

Slides:



Advertisements
Similar presentations
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Advertisements

MDR-TB GLOBALLY AND IN THE REGION 2013 Dr Samiha Baghdadi Medical officer – STB WHO – EMRO Cairo March 2014.
Country Update: Tuberculosis in Thailand
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo.
World Tuberculosis Day 2015 The TB situation in 2013: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Module 3: Drug-Resistant TB. Learning Objectives Describe how drug resistance emerges Explain the difference between primary and secondary resistance.
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
The Global Plan to Stop TB, (1)
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
Three key messages on tuberculosis control World Tuberculosis Day 2010 ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Extrapulmonary Site 2 :_____________________ Name (surname, first name) Age (in years) Sex F Alternative address Physical Address (in full) M INTERIM TUBERCULOSIS.
Tuberculosis in England 2015 report (presenting data to end of 2014) Tables and figures slide set.
Progress of the Singapore TB Elimination Programme (STEP)
Tuberculosis Surveillance in Europe EuroTB update March 2008 WHO Collaborating Centre.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
Exercise on TB clinical epidemiology: what are the indicators suggesting? G.B. Migliori WHO Collaborating Centre for Control of TB and Lung Diseases,
Global Tuberculosis Control 2007 Did we reach the 2005 targets? Will we achieve the Millennium Development Goals?
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
PMDT in Japan June 2016 Takashi Yoshiyama. Proportion of drug resistance, Japan (Ryoken sampling survey) Without treatment
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.
TB- HIV Collaborative activities in Romania- may 2006 status
World Tuberculosis Day 2014
Philippe Glaziou Geneva, 12 October 2009
World Tuberculosis Day 2013
World Tuberculosis Day 2014
Free State TB Information
Fifth Pacific Stop TB meeting Fiji Islands, May 4-7, 2010
MDR-TB Update Dr Kelvin Charambira
World Tuberculosis Day 2015
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Mean annual percentage change in TB notification rates,
Tuberculosis situation in the EU/EEA, 2016
Nino Mdivani NTP of Georgia
World Tuberculosis Day 2014
World Tuberculosis Day 2016
World Tuberculosis Day 2014
TUBERCULOSIS SURVEILLENCE KENYA
Sub-regional and metropolitan TB in Hungary in 2002
FRANCIS GAUSI and THOMAS NYIRENDA MALAWI.
Tuberculosis in Wales Annual Report 2018 Data to the end of 2017
Buhera District.
SURVEILLANCE AND EPIDEMIOLOGY OF TUBERCULOSIS IN FIJI
Goal Objectives Expected Outcomes
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
National Tuberculosis Control Program Department of Health Philippines Dr. Vivian S. Lofranco Medical Specialist IV.
Cheng shiming National TB Center in China May,3, 2004
Tuberculosis in Japan Annual Report Tuberculosis Surveillance
Tuberculosis in Slovakia
Surveillance of Tuberculosis
National Tuberculosis Control Program in Vietnam
EXERCISE 11: Computing and Analyzing Program Indicators
SLOVENIA.
TB epidemiology in Bulgaria
Epidemiology of Tuberculosis in Hong Kong
Communicable Disease Surveillance Centre, London
Country presentation Dr.Vija Riekstina National TB registry
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis in Wales Annual Report 2017 Data to the end of 2016
Tuberculosis situation in the EU/EEA, 2017
Presentation transcript:

Success and failure in TB surveillance in Hungary Dr. J. Mester, Dr. I. Vadász, Dr. D. Kozma Korányi Natl. Inst. TB and Pulmonology, Budapest, Hungary Tuberculosis Surveillance Centre

New TB cases in Hungary (1950-2001)

Trend of TB incidence in Hungary

Tuberculosis notification rates in Hungary 2002 Czech Republic 15.9 Tuberculosis notification rates in Hungary 2002 Slovakia 22.6 Ukraine 64.9 30.4 43.4 24.9 Austria 14.7 27.9 33.7 Budapest 24.8 38.7 39.1 28.4 Romania 119.9 14.5 33.3 14.7 24.5 16.3 21.4 Slovenia 22.0 29.3 Rate per 100,000 inhabitants 24.6 15.2 22.4 < 20 19.9 20-25 Yugoslavia 28.4 Croatia 39.5 25-35 35-45 > 45

TB incidence by age groups and sex in Hungary, 2002

Risk factors of new TB cases, 2002

Proportion of DST (1999-2001) 67% 65% 35% Not representative!

Initial drug-resistance in 2002 Previously Drug sensitivity test done Resistant to any drugs INH resistant MDR INH+RMPresistant Not treated 678 (70%) 87 (13%) 52 (8%) 13 (2%) Treated 123 (54%) 31 (25%) 20 (16%) 8 (7%) All cases 801 (68%) 118 (15%) 72 (9%) 21 (3%)

Case detection rate in Hungary, 2002 % Estimated real incidence Total notification 3007 100 2684 Bact. confirmed 1254 37 1556 58 Bact. not confirmed 1762 63 1128 42 Case detection rate of bact. conf. cases: 80% Bact. not confirmed cases: 63% (1762) 36% of them is overdiagnosed (643) Real incidence of bact. not confirmed cases: 41% (1128)

Notified afterwards 201 (49%) cases Drug sensitivity tests done in 1197 cases Of them 413 (34%) were not notified by the National TB Surveillance Center (NTSC)  Notified afterwards 201 (49%) cases  No information about 212 (17%) cases

Treatment Outcome Monitoring for Pulmonary Smear-Positive cases, 2001 New Retreated n=584 n=136 Cured 188 (32%) 29(21%) Completed 83 (14%) 14(10%) Died 96 22 Failed 66 33 Defaulted 38 8 Still on treatment 106 (18%) 25(18%) Transferred out 0 0 Unknown 6 5

Treatment Outcome Monitoring for Pulmonary Culture Positive cases, 2001 New Retreated n=810 n=185 Cured 299 (37%) 54 (30%) Completed 135 (16%) 24 (13%) Died 113 24 Failed 77 43 Defaulted 56 11 Still on treatment 125 (15%) 25 (13%) Transferred out 0 0 Unknown 5 4

Initial treatment of pulmonary TB cases in 2002 Smear and culture positive cases Only culture positive cases Bacteriologically not confirmed cases 3 drugs 165 (25%) 175 (36%) 1240 (74%) 4 or more drugs 432 (67%) 200 (41%) 312 (19%)

Outstanding analytical problems High proportion of bacteriologically not confirmed cases (~60%) Possible reasons: Overdiagnosis/misdiagnosis of TB Deficiency in bacteriologic diagnosis

Outstanding analytical problems 1. Békés county: Proportion of bacteriologically not confirmed cases was 80% After individual supervision of cases, 36% of them proved overdiagnosed („inactive” TB) or misdiagnosed (i.e. cancer)

Outstanding analytical problems 2. Number of notified cases in 2002: 3007 Bact. not confirmed: 1882 (63%) Culture negative: 1329 (70%) Culture not done: 553 (30%) Unsatisfactory communication among TB labs-hospitals-chest clinincs  bact. results sometimes disappear Modification of flow of informationTB labs will inform the NTSC NTSC conveys the results to the proper institution

Conclusion To improve the quality of TB control it is necessary To increase the proportion of bacteriologically confirmed cases To diminish the proportion of previously treated cases To increase the proportion of initial drug sensitivity tests To adjust the treatment to national and international guidelines To modify information flow